The global population is ageing and this demographic shift has profound effects on haemostasis, notably a progressive tilt ...
The startup, which has a pair of medicines in testing and others in development, aims to build the “ultimate coagulation ...
LES ULIS, France--(BUSINESS WIRE)--LFB received from the German regulatory authority (Paul-Ehrlich-Institute) a positive review feedback for the closing of the Mutual Recognition Procedure (MRP) of ...
Findings showed that routine prophylaxis with wilate resulted in an 84% reduction in mean total ABRs compared with on-demand treatment. The Food and Drug Administration (FDA) has expanded the approval ...
Wilate is used to prevent or treat bleeding in people with certain bleeding disorders. Allergic reactions and dizziness are common side effects. Get emergency help if you have chest pain, chest ...
Abstract: von Willebrand disease is a common inherited bleeding disorder characterized by excessive mucocutaneous bleeding. Characteristic bleeding symptoms include epistaxis, easy bruising, oral ...
For both type 1 and type 2 von Willebrand disease, higher BMI was associated with increased VWF:Ag and FVIII:C levels. Body mass index (BMI; calculated as the weight in kilograms divided by height in ...
Inhibitor Development Risk Similar for Factor VIII Products For children with severe hemophilia A, the risk of inhibitor development is similar with plasma-derived and recombinant factor VIII products ...
Imagine a first date or presenting in front of a large group and suddenly developing a serious, uncontrollable nosebleed that you don’t know how to stop. Or having heavy menstrual periods that last ...
The US Food and Drug Administration (FDA) has approved the first recombinant von Willebrand factor, to be used for the on-demand treatment and control of bleeding disorders in adults aged 18 years and ...
Von Willebrand disease (vWD) is the most common inherited bleeding disorder and affects approximately 1% of the population. Scientists from Cleveland Clinic and Cornell University have designed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback